These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30417774)

  • 41. Pharmacology and chemistry of diabetes mellitus and antidiabetic drugs: a critical review.
    Kokil GR; Rewatkar PV; Verma A; Thareja S; Naik SR
    Curr Med Chem; 2010; 17(35):4405-23. PubMed ID: 20939806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New drug targets for type 2 diabetes and the metabolic syndrome.
    Moller DE
    Nature; 2001 Dec; 414(6865):821-7. PubMed ID: 11742415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polysaccharides from Chinese herbal medicine for anti-diabetes recent advances.
    Zheng Y; Bai L; Zhou Y; Tong R; Zeng M; Li X; Shi J
    Int J Biol Macromol; 2019 Jan; 121():1240-1253. PubMed ID: 30342938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salicylates as hypoglycemic agents.
    Baron SH
    Diabetes Care; 1982; 5(1):64-71. PubMed ID: 6754304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development.
    Li Z; Qiu Q; Geng X; Yang J; Huang W; Qian H
    Expert Opin Investig Drugs; 2016 Aug; 25(8):871-90. PubMed ID: 27171154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural Alkaloids Intervening the Insulin Pathway: New Hopes for Anti-Diabetic Agents?
    Christodoulou MI; Tchoumtchoua J; Skaltsounis AL; Scorilas A; Halabalaki M
    Curr Med Chem; 2019; 26(32):5982-6015. PubMed ID: 29714135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 48. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders.
    Shah U; Kowalski TJ
    Vitam Horm; 2010; 84():415-48. PubMed ID: 21094910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin glargine: a long acting insulin analog.
    Chakkarwar PN; Manjrekar NA
    J Postgrad Med; 2005; 51(1):68-71. PubMed ID: 15793346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antidiabetic Effects of Simple Phenolic Acids: A Comprehensive Review.
    Vinayagam R; Jayachandran M; Xu B
    Phytother Res; 2016 Feb; 30(2):184-99. PubMed ID: 26634804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.
    Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
    Biochem Biophys Res Commun; 2010 Nov; 402(2):280-5. PubMed ID: 20937249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 54. Coumarins as potential antidiabetic agents.
    Li H; Yao Y; Li L
    J Pharm Pharmacol; 2017 Oct; 69(10):1253-1264. PubMed ID: 28675434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent development of single preparations and fixed-dose combination tablets for the treatment of non-insulin-dependent diabetes mellitus : A comprehensive summary for antidiabetic drugs.
    Li J; Lian H
    Arch Pharm Res; 2016 Jun; 39(6):731-46. PubMed ID: 27230777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Systematic Review of the Medicinal Potential of Mulberry in Treating Diabetes Mellitus.
    Wei H; Liu S; Liao Y; Ma C; Wang D; Tong J; Feng J; Yi T; Zhu L
    Am J Chin Med; 2018; 46(8):1743-1770. PubMed ID: 30518235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidiabetic Potential of
    Zulcafli AS; Lim C; Ling AP; Chye S; Koh R
    Yale J Biol Med; 2020 Jun; 93(2):307-325. PubMed ID: 32607091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug repositioning for diabetes based on 'omics' data mining.
    Zhang M; Luo H; Xi Z; Rogaeva E
    PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion.
    Yoshida S; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Sep; 400(3):437-41. PubMed ID: 20804735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
    Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
    Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.